// App-Quantinova.ai

: Reduced Intensity Reinduction Followed By Blinatumomab Achieves Excellent MRD Clearance with Reduced Toxicity and Facilitates Timely Transplant in Children and Young People with Relapsed B-Precursor Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Angus Hodder

Principal Investigators

  • Katherine Clesham

  • Susan Baird

  • Kaljit Bhuller

  • Ismail Bisho

  • Denise Bonney

  • Anna Castleton

  • Michelle Cummins

  • Emmy Dickens

  • Lindsay George

  • Sara Ghorashian

  • Brenda Gibson

  • Chris Hasley

  • Nicholas Heaney

  • Rachael E Hough

  • Danielle Ingham

  • Galina Jigoulina

  • Katherine Lindsay

  • Donna Lancaster

  • Majid Madni

  • Andrea Malone

  • Bethany Mitchell

  • Anthony V. Moorman

  • John Moppett

  • Vanessa McLelland

  • Jayashree Motwani

  • Emma Nicholson

  • Caroline Osborne

  • Katharine Patrick

  • Lamia Samrin

  • Sanjay Tewari

  • Indu Rakesh Thakur

  • Sujith Samarasinghe

  • Ajay Vora

  • David O'Connor

Medical Centers

  • The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Haematology, UCLH, London, United Kingdom

  • Children's Hospital For Wales, Cardiff, GBR

  • Cancer Institute, University College London, London, United Kingdom

  • Haematology, Sheffield Children's NHS Foundation Trust, London, United Kingdom

  • Our Lady's Children Hospital, Crumlin, IRL

  • School of Cancer Sciences, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, GBR

  • Department of Haematology, University College London Hospitals NHS Trust, London, United Kingdom

  • Haematology, University college London hospital, london, United Kingdom

  • The Royal Hospital for Children, Glasgow, United Kingdom

  • Wolfson Childhood Cancer Research Centre, Newcastle University, Newcastle, United Kingdom

  • University Hospitals of Leicester NHS Trust, Leicester, United Kingdom

  • Great Ormond Street Hospital, London, United Kingdom

  • Nottingham University Hospitals, Nottingham, GBR

  • Haematology, Royal Belfast Hospital for Sick Children, Belfast, United Kingdom

  • Haematology, Alder Hey Children's Hospital Trust, LIverpool, United Kingdom

  • Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom

  • Department of Haematology, Royal Hospital for Sick Children, Edinburgh, United Kingdom

  • Department of Hematology, Great Ormond Street Hospital for Children, London, United Kingdom

  • Haematology, Leeds Children's Hospital, Leeds, GBR

  • Royal Manchester Children's Hospital, Manchester, GBR

  • Birmingham Children's Hospital, Birmingham, GBR

  • Haematology, The Royal Marsden, London, United Kingdom

  • Birmingham Children's Hospital, Birmingham, United Kingdom

  • Department of Haematology, Bristol Children's Hospital, Bristol, United Kingdom

  • Haematology, Oxford University Hospital NHS Trust, Oxford, United Kingdom

  • Royal Hospital For Children, Glasgow, GBR

  • Department of Haematology, Bristol Children's Hospital, Bristol, GBR

  • Haematology, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved